Market Overview

The China Artificial Intelligence (AI) In Healthcare Market reached a market size of USD 1,285.8 million in 2024. It is expected to grow at a CAGR of 23.50% between 2025 and 2033, reaching USD 8,593.3 million by 2033. This growth is driven by rapid advancements in machine learning, deep learning, and natural language processing, alongside increasing government support and a rising elderly population demanding efficient healthcare solutions.

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

China Artificial Intelligence (AI) In Healthcare Market Key Takeaways

• The China artificial intelligence (AI) in healthcare market size was USD 1,285.8 million in 2024.
• The market is expected to grow at a CAGR of 23.50% during 2025-2033.
• The forecast period for the market extends from 2025 to 2033.
• Technological advancements in machine learning, deep learning, and natural language processing are propelling market growth.
• Government initiatives such as the State Council's "A Next Generation Artificial Intelligence Development Plan" bolster AI adoption in healthcare.
• The rising geriatric population is creating higher demand for AI-driven healthcare solutions.
• AI enables improved diagnostic accuracy and efficiency, as well as personalized patient care.

Sample Request Link: https://www.imarcgroup.com/China-Artificial-Intelligence-In-Healthcare-Market/requestsample

Market Growth Factors

Technological advancements, including artificial intelligence (AI), machine learning, deep learning, and natural language processing (NLP), are pushing the growth of China's healthcare market further. AI systems are contributing towards the evolution of diagnostics, treatment planning, monitoring, and patient management. Example applications include artificial intelligence (AI) that can detect disease from patients more quickly and accurately than a human can, using tools such as computer image analysis of x-rays or other imaging data. The AI software X-Raydar was developed by the University of Warwick and King's College London. Predictive analytics may also help with intervening proactively to lower the risk.

In China, the government is strongly supporting the use of AI in healthcare. The State Council's "A Next Generation Artificial Intelligence Development Plan" includes the goal for China to become world-leading in AI by 2030 in healthcare and healthcare-related technology. Among these is a provision for funding of AI startups and financial incentives for the adoption of AI technologies across various healthcare institutions.

Due to the ageing population of the nation and the rise in chronic and geriatric diseases, the use of AI applications in medicine can help optimize healthcare by individualizing care and optimizing resource allocation. Applications can assist in personalized medical care, managing huge amounts of information, and assist with healthcare in the elderly, especially in rural areas where it is helping reduce hospital visits and the strain on healthcare facilities.

Market Segmentation

Offering Insights:

• Hardware
• Software
• Services

Technology Insights:

• Machine Learning
• Context-Aware Computing
• Natural Language Processing
• Others

Application Insights:

• Robot-Assisted Surgery
• Virtual Nursing Assistant
• Administrative Workflow Assistance
• Fraud Detection
• Dosage Error Reduction
• Clinical Trial Participant Identifier
• Preliminary Diagnosis
• Others

End User Insights:

• Healthcare Providers
• Pharmaceutical and Biotechnology Companies
• Patients
• Others

Region Insights:

• North China
• East China
• South Central China
• Southwest China
• Northwest China
• Northeast China

Request Customization:

https://www.imarcgroup.com/request?type=report&id=23440&flag=E 

Regional Insights

The report covers all major regions of China, including North China, East China, South Central China, Southwest China, Northwest China, and Northeast China. The regional markets contribute collectively to the overall growth trajectory, driven by growing healthcare demands and adoption of AI technologies across these diverse geographic areas.

Recent Developments & News

In May 2024, researchers at Tsinghua University developed an AI hospital called "Agent Hospital," where doctors, nurses, and patients are managed by large language model (LLM)-powered intelligent agents with autonomous interaction capabilities. In March 2024, China planned to test an AI assistant for neurosurgeons at seven hospitals in Beijing and other cities. Additionally, a Hong Kong-based agency under the Chinese Academy of Sciences introduced an AI model built on Meta Platform Inc.’s Llama 2.0 researchers.

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Customization Note

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302